Search

everythinglearnresearchcommunity

for

Search:↓

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Stem cell therapies may help improve symptoms and quality of life for people with epidermolysis bullosa.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Low CD4 counts in HIV patients are linked to more skin disorders.

The immune system can cause permanent skin and hair whitening by attacking pigment cells.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Mesenchymal stem-cell derived extracellular vesicles show promise in plastic surgery but need more research for safe use.

Dermal sheath cells help heal wounds by showing both skin and connective tissue traits.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

Farudodstat may help treat alopecia areata by protecting hair follicles.

A300 membranes help skin heal faster by promoting cell growth and repair.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Staphylococcus aureus affects immune responses and skin cells in atopic dermatitis, suggesting new treatment targets.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Different γδ T cell types have unique roles in causing alopecia areata.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Potential therapeutic targets for scarring hair loss are identified.

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.

Different types of inactive melanocyte stem cells exist with unique characteristics and potential to develop into other cells.